251164 — Grand Rapids, Michigan

251164 is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

251164 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma.

Sponsors: GlaxoSmithKline.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grand Rapids

Browse all research sites in Michigan · View every site in Grand Rapids

• Helen DeVos Children's Hospital CF Care Center
• Helen DeVos Childrens Hospital /ID# 79397
• Spectrum Health Hospitals Fred and Lena Meijer Heart Center
• Spectrum Health and DeVos Children's Hospital
• Trinity Health Grand Rapids Hospital
• Spectrum Health Hospital
• Corewell Health Medical Group and Spectrum Health Hospitals
• Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group
• Mercy Health Saint Mary's Hospital
• Helen DeVos Children's Hospital Pediatric Ophthalmology
• Blodgett Hospital
• Spectrum Health Helen DeVos Children's Hospital Grand Rapids

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 251164?

251164 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 251164 conducted?

251164 has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma.

Is 251164 accredited by Crixeo Clinical Trials?

251164 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 251164?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.